نتایج جستجو برای: primary and metastatic melanoma

تعداد نتایج: 16947239  

Journal: :Diagnostic Pathology 2007
Deepali Jain Tejindar singh Naresh Kumar Mradul K Daga

BACKGROUND Metastases of malignant melanoma to the bone marrow are very rare. A few case reports are published in the literature with a known primary site. CASE PRESENTATION Herein we present a case of metastatic malignant melanoma in bone marrow with occult primary site in a 22-year-old-male. Diagnosis was confirmed by morphology and immunohistochemistry. A pertinent review of literature is ...

Journal: :international journal of hematology-oncology and stem cell research 0
mehrdad payandeh department of hematology, kermanshah university of medical science, kermanshah , iran mehrnoush aeinfar department of hematology, kermanshah university of medical science, kermanshah , iran ali maleki hematology center , kermanshah university of medical science, iran mmohammad erfan zare student of research center , kermanshah university of medical science, iran

introduction: the incidence of malignant melanoma is increasing at a rate greater than any other human cancer. although melanoma accounts for only 4 percent of all dermatologic cancers, it is responsible for 80 percent of deaths from skin cancer; only 14 percent of patients with metastatic melanoma survive for five years. the optimal therapy varies with the stage of the disease. surgical excisi...

2017
Saad Abdalla Al-Zawi

Metastatic lesions in the breast from malignant diseases originated in other primary sources are rare. Mostly arise from the contra-lateral breast. The incidence extramammary origin of the breast metastasis is 1.2-2%. The usual extra-mammary primary sites of metastasis are malignant melanoma, lung cancer and Non-Hodgkin lymphoma. In any patient who has been diagnosed with a known primary cancer...

2011
Jinah Kim Salma Dabiri E. Scott Seeley

Cutaneous melanoma is a lethal malignancy that arises spontaneously or via in situ precursor neoplasms. While melanoma in situ and locally invasive malignant melanoma can be cured surgically, these lesions can sometimes be difficult to distinguish from melanocytic nevi. Thus, the identification of histolopathologic or molecular features that distinguish these biologically distinct lesions would...

2013
Germana Sini Maria Colombino Amelia Lissia Sara Maxia Marcello Gulino Panagiotis Paliogiannis Grazia Palomba Giuseppe Palmieri Antonio Cossu Corrado Rubino

INTRODUCTION Primary dermal melanoma (PDM) is a recently described clinical entity accounting for less than 1% of all melanomas. Histologically, it is located in the dermis or subcutaneous tissue, and it shows no connections with the overlying epidermis. The differential diagnosis is principally made along with that of metastatic cutaneous melanoma. CASE REPORT A 72-year-old Caucasian woman w...

2015
Bingjun Yang Qingzhao Li Hui Zhao Huibin Liu Tao Tang Chunyang Jiang

BACKGROUND Oral malignant melanoma (OMM) is an aggressive tumor with very low survival rate and easy to metastasize. Pleural metastatic melanoma via primary OMM is rare. CASE PRESENTATION In this report, we presented a case of metastatic malignant melanoma of the pleura originated from OMM. A 54-year-old man without primary skin lesion was diagnosed multiple nodular shadows, pleural invasion,...

Journal: :Molecular cancer research : MCR 2017
Carlos I Rodríguez Edgardo Castro-Pérez Kirthana Prabhakar Laura Block B Jack Longley Jaclyn A Wisinski Michelle E Kimple Vijayasaradhi Setaluri

Cyclic AMP (cAMP) is an important second messenger that regulates a wide range of physiologic processes. In mammalian cutaneous melanocytes, cAMP-mediated signaling pathways activated by G-protein-coupled receptors (GPCR), like melanocortin 1 receptor (MC1R), play critical roles in melanocyte homeostasis including cell survival, proliferation, and pigment synthesis. Impaired cAMP signaling is a...

Journal: :Clinical cancer research : an official journal of the American Association for Cancer Research 2013
Loretta Gammaitoni Lidia Giraudo Valeria Leuci Maja Todorovic Giulia Mesiano Franco Picciotto Alberto Pisacane Alessandro Zaccagna Maria Giuseppa Volpe Susanna Gallo Daniela Caravelli Elena Giacone Tiziana Venesio Antonella Balsamo Ymera Pignochino Giovanni Grignani Fabrizio Carnevale-Schianca Massimo Aglietta Dario Sangiolo

PURPOSE We investigate the unknown tumor-killing activity of cytokine-induced killer (CIK) cells against autologous metastatic melanoma and the elusive subset of putative cancer stem cells (mCSC). EXPERIMENTAL DESIGN We developed a preclinical autologous model using same patient-generated CIK cells and tumor targets to consider the unique biology of each patient/tumor pairing. In primary tumo...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید